المؤلفون: Andavar M; Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603 203, India., Kamaraj R; Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603 203, India. Electronic address: kamarajr@srmist.edu.in., Mahalingam Vijayakumar T; Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603 203, India., Murugesan A; Department of Obstetrics and Gynaecology, Faculty of Medicine, SRM Medical College Hospital and Research Centre, Kattankulathur, Tamil Nadu 603 203, India.

المصدر: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Sep; Vol. 300, pp. 6-11. Date of Electronic Publication: 2024 Jul 03.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7654 (Electronic) Linking ISSN: 03012115 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol Subsets: MEDLINE

مواضيع طبية MeSH: Polycystic Ovary Syndrome*/drug therapy , Polycystic Ovary Syndrome*/complications , Metformin*/therapeutic use , Metformin*/administration & dosage , Inositol*/administration & dosage , Inositol*/therapeutic use , Acarbose*/therapeutic use , Acarbose*/administration & dosage , Drug Therapy, Combination* , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/administration & dosage, Humans ; Female ; Adult ; Young Adult ; Insulin Resistance ; Follicle Stimulating Hormone/blood ; Luteinizing Hormone/blood ; Treatment Outcome

المؤلفون: Mao PC; Department of Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Pharmacy, National Defense Medical Center, Taipei, Taiwan., Chung MI; School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan., Hung YM; Division of Nephrology, Taipei Veterans General Hospital Taitung Branch, Taitung, Taiwan.; Master Program in Biomedicine, National Taitung University, Taitung, Taiwan.; College of Health and Nursing, Meiho University, Neipu, Pingtung, Taiwan., Chen HM; Department of Business Administration, I-Shou University, Kaohsiung, Taiwan.; Department of Medical Education and Research and Research Center of Medical Informatics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan., Chen CL; Department of Medical Education and Research and Research Center of Medical Informatics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Division of Nephrology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.; Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Faculty of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.

المصدر: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Sep; Vol. 33 (9), pp. e5762.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Acarbose*/therapeutic use , Acarbose*/administration & dosage , Stomach Neoplasms*/epidemiology, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Taiwan/epidemiology ; Aged ; Cohort Studies ; Adult ; Diabetes Mellitus/epidemiology ; Databases, Factual ; Proportional Hazards Models ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/adverse effects ; Risk Factors ; Severity of Illness Index

المؤلفون: Zhang P; Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA., Lee J; Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA., Feng K; Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA., Babiskin A; Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA., Yoon M; Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA., Fang L; Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA., Zhao L; Division of Quantitative Methods & Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland, USA.

المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Sep; Vol. 90 (9), pp. 2320-2322. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article; Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Therapeutic Equivalency* , Acarbose*/pharmacokinetics , Acarbose*/administration & dosage , Acarbose*/pharmacology , Hypoglycemic Agents*/pharmacokinetics , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/therapeutic use, Humans ; Glycoside Hydrolase Inhibitors/pharmacokinetics ; Glycoside Hydrolase Inhibitors/administration & dosage ; Glycoside Hydrolase Inhibitors/pharmacology

المؤلفون: Andavar M; SRM College of Pharmacy, Department of Pharmacy Practice, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India., Kamaraj R; SRM College of Pharmacy, Department of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India., Vijayakumar TM; SRM College of Pharmacy, Department of Pharmacy Practice, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India., Murugesan A; SRM Medical College Hospital and Research Centre, Department of Obstetrics and Gynaecology, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India.

المصدر: Current medical research and opinion [Curr Med Res Opin] 2024 Jul; Vol. 40 (7), pp. 1123-1135. Date of Electronic Publication: 2024 Jun 09.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE

مواضيع طبية MeSH: Acarbose*/therapeutic use , Polycystic Ovary Syndrome*/drug therapy , Polycystic Ovary Syndrome*/complications, Female ; Humans ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/adverse effects ; Insulin Resistance

المؤلفون: Jiang Z; Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA., He Q; Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA., Wezeman J; Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA., Darvas M; Department of Laboratory Medicine and Pathology, School of Medicine, University of Washington, Seattle, WA, USA., Ladiges W; Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA. wladiges@uw.edu.

المصدر: GeroScience [Geroscience] 2024 Oct; Vol. 46 (5), pp. 4855-4868. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE

مواضيع طبية MeSH: Acarbose*/pharmacology , Cognitive Dysfunction*/prevention & control , Cognitive Dysfunction*/drug therapy , Sirolimus*/pharmacology , Phenylbutyrates*/pharmacology, Animals ; Male ; Mice ; Hippocampus/drug effects ; Hippocampus/metabolism ; Mice, Inbred C57BL ; Aging/drug effects ; Drug Therapy, Combination ; Autophagy/drug effects ; Disease Models, Animal ; Transcriptome/drug effects

المؤلفون: Kumar A; School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi 221005, India., Kumar Singh V; School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi 221005, India., Kayastha AM; School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi 221005, India. Electronic address: kayasthabhu@gmail.com.

المصدر: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Jun 05; Vol. 314, pp. 124160. Date of Electronic Publication: 2024 Mar 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9602533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3557 (Electronic) Linking ISSN: 13861425 NLM ISO Abbreviation: Spectrochim Acta A Mol Biomol Spectrosc Subsets: MEDLINE

مواضيع طبية MeSH: Acarbose*/pharmacology , Acarbose*/chemistry , Quercetin*/metabolism, Glycoside Hydrolase Inhibitors/chemistry ; alpha-Amylases/metabolism ; Circular Dichroism ; Molecular Docking Simulation

المؤلفون: Lobato CB; Department of Medicine, Copenhagen University Hospital, Amager and Hvidovre, Section of Endocrinology, Hvidovre, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Winding CT; Department of Medicine, Copenhagen University Hospital, Amager and Hvidovre, Section of Endocrinology, Hvidovre, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Bojsen-Møller KN; Department of Medicine, Copenhagen University Hospital, Amager and Hvidovre, Section of Endocrinology, Hvidovre, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Martinussen C; Department of Medicine, Copenhagen University Hospital, Amager and Hvidovre, Section of Endocrinology, Hvidovre, Denmark., Veedfald S; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Holst JJ; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Novo Nordisk Foundation Centre for Basic Metabolic Research, Copenhagen, Denmark., Madsbad S; Department of Medicine, Copenhagen University Hospital, Amager and Hvidovre, Section of Endocrinology, Hvidovre, Denmark., Jørgensen NB; Department of Medicine, Copenhagen University Hospital, Amager and Hvidovre, Section of Endocrinology, Hvidovre, Denmark., Dirksen C; Department of Medicine, Copenhagen University Hospital, Amager and Hvidovre, Section of Endocrinology, Hvidovre, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

المصدر: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 Jun; Vol. 41 (6), pp. e15320. Date of Electronic Publication: 2024 Mar 29.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5491 (Electronic) Linking ISSN: 07423071 NLM ISO Abbreviation: Diabet Med Subsets: MEDLINE

مواضيع طبية MeSH: Acarbose*/therapeutic use , Canagliflozin*/therapeutic use , Hypoglycemia*/prevention & control , Hypoglycemia*/chemically induced, Adult ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Blood Glucose/metabolism ; Blood Glucose/drug effects ; Cross-Over Studies ; Double-Blind Method ; Gastric Bypass/adverse effects ; Hypoglycemic Agents/therapeutic use ; Postoperative Complications/drug therapy ; Postoperative Complications/prevention & control ; Randomized Controlled Trials as Topic ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use

المؤلفون: David H; Quorum Sensing Laboratory, Centre for Research in Infectious Diseases (CRID), School of Chemical and Biotechnology, SASTRA Deemed to be University, Thanjavur, 613401, India., Vasudevan S; Quorum Sensing Laboratory, Centre for Research in Infectious Diseases (CRID), School of Chemical and Biotechnology, SASTRA Deemed to be University, Thanjavur, 613401, India. savvysahana@gmail.com.; Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, 560065, India. savvysahana@gmail.com., Solomon AP; Quorum Sensing Laboratory, Centre for Research in Infectious Diseases (CRID), School of Chemical and Biotechnology, SASTRA Deemed to be University, Thanjavur, 613401, India. adlineprinzy@sastra.ac.in.

المصدر: Scientific reports [Sci Rep] 2024 May 24; Vol. 14 (1), pp. 11890. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Candida albicans*/drug effects , Candida albicans*/pathogenicity , Acarbose*/pharmacology , alpha-Glucosidases*/metabolism , alpha-Glucosidases*/genetics , Antifungal Agents*/pharmacology , Candidiasis*/drug therapy , Candidiasis*/microbiology, Glycoside Hydrolase Inhibitors/pharmacology ; Humans ; Biofilms/drug effects ; Biofilms/growth & development ; Computer Simulation ; Cell Wall/metabolism ; Cell Wall/drug effects ; Transcriptome ; Fungal Proteins/metabolism ; Fungal Proteins/genetics ; Molecular Docking Simulation ; Virulence/drug effects

المؤلفون: Punia R; Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India., Mor S; Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India. Electronic address: satbir_mor@yahoo.co.in., Sindhu S; Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India., Kumar D; Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan 173229, India., Pradip Das P; Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan 173229, India., Kumar Jindal D; Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology, Hisar 125001, India., Kumar A; Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology, Hisar 125001, India., Mohil R; Department of Chemistry, Government College, Nalwa, Hisar, Haryana 125001, India., Jakhar K; Department of Chemistry, Maharshi Dayanand University, Rohtak, Haryana 124001, India.

المصدر: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2024 May 01; Vol. 103, pp. 129692. Date of Electronic Publication: 2024 Mar 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

مواضيع طبية MeSH: Acarbose* , Glucose*, Structure-Activity Relationship ; Molecular Structure ; Molecular Docking Simulation ; alpha-Amylases/metabolism ; Benzothiazoles/pharmacology ; alpha-Glucosidases/metabolism ; Glycoside Hydrolase Inhibitors/pharmacology

المؤلفون: Que L; Drug Clinical Trial Institution, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China., Qian Z; Drug Clinical Trial Institution, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China., Xiang X; Drug Clinical Trial Institution, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China., Ding Y; Drug Clinical Trial Institution, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China., Huang K; Drug Clinical Trial Institution, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China., Bai Y; Beijing Bokangjian Gene Technology Co., Ltd, Beijing, China., Zhao H; Beijing Bokangjian Gene Technology Co., Ltd, Beijing, China., He Q; Drug Clinical Trial Institution, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Mar; Vol. 13 (3), pp. 233-239. Date of Electronic Publication: 2024 Jan 10.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Acarbose* , Diabetes Mellitus, Type 2*/drug therapy, Humans ; China ; Glucose ; Sucrose ; Therapeutic Equivalency